Results for this period
Interim period (second quarter)1 December 2025–31 May 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in million yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The HBC and Food business benefited from the consolidation of the 池田物産 Group. In the Chemicals business, growth was driven by investment related to package substrates accompanying the rapid expansion of the generative AI market, the acquisition of new customers in China, a recovery in demand for chemicals used in printed circuit boards, and increased sales of equipment to major customers and in repair and maintenance services.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 December 2025–31 May 2026 |
| Net Sales | 34,566 million yen (YoY +14.8%) |
| Operating profit | 2,294 million yen (YoY +3.2%) |
| Ordinary income | 2,148 million yen (YoY -0.0%) |
| Profit attributable to owners of the parent | 1,417 million yen (YoY +10.0%) |
| Net income per share | ¥35.10 |
| Equity ratio | End of the current fiscal period 38 / End of previous period 35.7 |
| Total assets | 74,864 million yen |
| Net assets | 28,796 million yen |
| Cash flows from operating activities | 2,566 million yen |
| Cash flows from investing activities | -1,468 million yen |
| Cash flows from financing activities | -2,593 million yen |
| Cash and cash equivalents at end of period | 8,640 million yen |
| Full-year earnings forecast | Net Sales 68,000 million yen (YoY +8.4%) / Operating profit 3,400 million yen (YoY +12.6%) / Ordinary income 3,300 million yen (YoY +13.3%) / Net income 2,350 million yen (YoY +7.2%) |
| Revision to Earnings Forecast | None |
| Annual Dividend Forecast | 18 yen → 18 yen（0.0%） |
| Segment revenue | Fine chemicals 10,930 million yen (YoY -5.4%), HBC and Food 11,359 million yen (YoY +41.7%), Pharmaceuticals 6,250 million yen (YoY +4.0%), Chemicals 5,989 million yen (YoY +33.1%), Other 35 million yen (YoY +107.2%) |
| Segment profit | Fine chemicals 729 million yen (YoY -16.3%), HBC and Food 360 million yen (YoY -33.9%), Pharmaceuticals 658 million yen (YoY -3.2%), Chemicals 606 million yen (YoY +218.3%), Other -128 million yen |
| Depreciation and amortization | 1,303 million yen |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets 0 million yen, Gain on sale of investment securities 0 million yen / Extraordinary loss Losses on disposal of fixed assets 6 million yen |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies (no company names provided) / Excluded 0 companies (no company names provided) |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 41,182,421 |
| Treasury Shares at Period-End | 751,878 |
| Factors Behind Changes in Business Performance | The HBC and Food business benefited from the consolidation of the 池田物産 Group. In the Chemicals business, growth was driven by investment related to package substrates accompanying the rapid expansion of the generative AI market, the acquisition of new customers in China, a recovery in demand for chemicals used in printed circuit boards, and increased sales of equipment to major customers and in repair and maintenance services. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue in the HBC and Food business increased due to the contribution of the 池田物産 Group, which has been consolidated since September 2025. In the Chemicals business, both revenue and profit increased substantially in the surface treatment chemicals and surface treatment equipment divisions.